BIIB
BIOGEN INC.
Key Financials
Operating Income
$2.8B
↓ 37.6%
Net Income
$1.3B
↓ 20.8%
Gross Profit
$11.6B
↑ 392.8%
Revenue
$9.9B
↑ 2.2%
EPS (Diluted)
$8.79
↓ 21.4%
Total Assets
$29.4B
↑ 5.0%
Shareholders' Equity
$14.8B
↑ 10.5%
Total Liabilities
$11.2B
↓ 1.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SC TO-T | 4/14/2026 | View on SEC |
| SC TO-C | 4/7/2026 | View on SEC |
| 3 | 4/6/2026 | View on SEC |
| SCHEDULE 13D | 4/6/2026 | View on SEC |
| 8-K | 4/6/2026 | View on SEC |
| SC TO-C | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| SC TO-C | 3/31/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| SC TO-C | 3/31/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BIIB |
| Company Name | BIOGEN INC. |
| CIK | 875045 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 7814642000 |